LARA'S Objectives
-
> Education
Promoting knowledge and awareness of LAM to practitioners and women with LAM -
> Information
Providing information for and about women with LAM -
> Support
Providing for the needs of women with LAM -
> Diagnosis
Facilitating diagnosis by raising awareness of LAM -
> Research
Fostering and funding research to discover the cause, cure and prevention of LAM -
> Fundraising
Raising money to support our objectives -
> Networking
Collaborating with countries in our region by exchanging information
Contact Us
LAM Australasia Research Alliance
4/209 Oxford Street
Bondi Junction 2022
Nevena 0419 185 491
Janet 0411 816 444
PO Box 636 Bondi Junction NSW 1355
Australia
|
Articles In: Research (Page 1 of 1)
|
|
Six month visit by Dr Lyn M Moir to Dr Vera Krymskaya’s laboratory, University of Pennsylvania, Philadelphia, PA, USA 01 June – 30 November 2007 Summary Pulmonary lymphangioleiomyomatosis (LAM) is a progressive and usually fatal rare lung disease which affects women of child bearing age predominantly. ...
|
|
Dr Deborah YatesDepartment of Thoracic MedicineSt Vincent's Hospital, SydneyIn 2008 we started enrolling women with LAM for the Doxycycline in LAM trial at St Vincent’s Hospital, Sydney. The first stage of the trial commenced in November 2008. Three women completed the first treatment phase (with either doxycycli...
|
|
In November 2009 researchers at the Malaghan Institute for Medical Research in Wellington New Zealand embarked on a one year pilot program studying LAM cells.This research initiative by the Malaghan Institute's Cancer Cell and Molecular Biology Group is supported by The New Zealand LAM Trust and the LAM Australasia Researc...
|